These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3079028)

  • 41. Clinical significance of albuminuria in renal transplantation.
    Yanagisawa T; Kuzuhara K; Nishimori S; Kurooka Y; Yamada A; Harihara Y; Yokota K; Ogura Y; Otsubo O; Inou T
    Transplant Proc; 1994 Aug; 26(4):2174-5. PubMed ID: 7915061
    [No Abstract]   [Full Text] [Related]  

  • 42. A controlled trial of triple therapy in renal transplantation.
    Salaman JR; Griffin PJ; Ross WB; Williams JD
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1935-6. PubMed ID: 3079061
    [No Abstract]   [Full Text] [Related]  

  • 43. Place of antilymphocyte globulins in the immunosuppressive regimen for kidney transplantation.
    Touraine JL; Lefrançois N; Dubernard JM; Garnier JL; Eygonnet JP; Gibelin N; Bétuel H; Traeger J
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1881. PubMed ID: 3079055
    [No Abstract]   [Full Text] [Related]  

  • 44. Cyclosporine-steroids versus conventional therapy in cadaver kidney transplantation: analysis of a randomized trial at two years.
    Gianello P; Squifflet JP; Pirson Y; Stoffel M; Dereme T; Alexandre GP
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1867-72. PubMed ID: 3547891
    [No Abstract]   [Full Text] [Related]  

  • 45. [Evaluation of the effectiveness of ALG in clinical kidney transplantation in alternating studies].
    Tidow G; Bunzendahl H; Wonigeit K; Pichlmayr R
    Chir Forum Exp Klin Forsch; 1979; ():325-8. PubMed ID: 378593
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of antilymphocyte globulin in cadaver renal transplantation.
    Novick AC
    Transplant Proc; 1986 Jun; 18(3 Suppl 2):22-7. PubMed ID: 3521000
    [No Abstract]   [Full Text] [Related]  

  • 47. Quadruple drug therapy prevents graft loss from acute rejection without increasing mortality.
    Light JA; Aquino A; Ali A; Rodriguez R; Ali S
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1927-30. PubMed ID: 3547897
    [No Abstract]   [Full Text] [Related]  

  • 48. Comparison of OKT3 and antithymocyte globulin as induction immunosuppressive agents in renal transplantation.
    Kitabayashi K; Munn SR; Sterioff S
    Transplant Proc; 1996 Jun; 28(3):1973-5. PubMed ID: 8658964
    [No Abstract]   [Full Text] [Related]  

  • 49. Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506.
    Woodle ES; Thistlethwaite JR; Haas M; Josephson MA; Newell KA; Bruce DS; Millis JM; Piper JB; Charette JI
    Transplant Proc; 1996 Apr; 28(2):998-9. PubMed ID: 8623495
    [No Abstract]   [Full Text] [Related]  

  • 50. Pretreatment of human renal allografts with monoclonal antibodies to induce long-term tolerance.
    Taube D; Welsh KI; Bewick M; Dische FE; Palmer A; Parsons V; Snowden S
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1961-3. PubMed ID: 3274456
    [No Abstract]   [Full Text] [Related]  

  • 51. Cardiac transplantation in the sixth decade of life.
    Szentpetery S; Thames M; Hanrahan J; Morris J; Lower RR
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2492-4. PubMed ID: 3079089
    [No Abstract]   [Full Text] [Related]  

  • 52. Early renal allograft rejection episodes are less aggressive with cyclosporin-A immunosuppression.
    Merion RM; White DJ; Calne RY
    Transplant Proc; 1983 Dec; 15(4):2172-7. PubMed ID: 6369690
    [No Abstract]   [Full Text] [Related]  

  • 53. Triple drug therapy: an alternative regimen in renal transplantation.
    Henry ML; Sommer BG; Ferguson RM
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1920-1. PubMed ID: 3079059
    [No Abstract]   [Full Text] [Related]  

  • 54. Immunohistology or conventional histology for the diagnosis of renal allograft rejection?
    McWhinnie DL; Hughes D; Fuggle SV; Dunnill MS; Carter NP; Morris PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1888-9. PubMed ID: 2652613
    [No Abstract]   [Full Text] [Related]  

  • 55. Cox regression analysis of outcome risk factors in 519 renal allograft recipients.
    Canafax DM; Savik SK; Draxler CA; Le CT; Ascher NL; Payne WD; Sutherland DE; Migliori RJ; Simmons RL; Najarian JS
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1947-8. PubMed ID: 3274455
    [No Abstract]   [Full Text] [Related]  

  • 56. Serum beta 2 microglobulin levels are relatively depressed in cyclosporine A-treated patients who undergo kidney graft rejection.
    Kootte AM; Henny FC; Moolenaar AJ; van Es LA; Paul LC
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1681-2. PubMed ID: 3079033
    [No Abstract]   [Full Text] [Related]  

  • 57. Intermodal immunosuppression for cadaver renal transplantation: results using antilymphocyte globulin, azathioprine, cyclosporine, and prednisone.
    Halloran P; Ludwin D; Bear R; Aprile M; McQuarrie B; Poole R; White N
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1931-2. PubMed ID: 3274454
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical renal transplantation.
    Sommer BG; Ferguson RM; Najarian JS
    Urol Clin North Am; 1983 Feb; 10(1):149-59. PubMed ID: 6340311
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection.
    Khosroshahi HT; Tubbs RS; Shoja MM; Ghafari A; Noshad H; Ardalan MR
    Transplant Proc; 2008; 40(1):137-9. PubMed ID: 18261569
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Postoperative endogenous serum cortisol levels as an index of acute rejection and severe infection in renal allograft recipients.
    Kozaki M; Hirano T; Oka K; Honma M; Kang X; Sakurai E; Tamaki T; Tamaki I
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1864-6. PubMed ID: 2652606
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.